Skip to content

Addiction: all studies

Page 452 of 855: studies 4,511 to 4,520 of 8,547, newest first. Back to the addiction overview

Research

Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders

Translational Perioperative and Pain Medicine June 29, 2022 Joseph Cichon, Renyu Liu, Hoang-Vinh Le

While the hallucinogenic plant Salvia divinorum has been safely consumed by humans for centuries for religious or recreational purposes without long-term side effects, its active component, salvinorin A, and molecular mechanism of action were not known until recently [1]. Notably, salvinorin A is a potent kappa opioid receptor (KOR) agonist that is highly selective for KOR without significant...

Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders

Frontiers in Pharmacology June 28, 2022 Nataliya S. Vorobyeva, Alena A. Kozlova 16 citations

Classical psychedelics represent a family of psychoactive substances with structural similarities to serotonin and affinity for serotonin receptors. A growing number of studies have found that psychedelics can be effective in treating various psychiatric conditions, including post-traumatic stress disorder, major depressive disorder, anxiety, and substance use disorders. Mental health disorders...

Psychedelic Therapies at the Crossroads of Trauma and Substance Use: Historical Perspectives and Future Directions, Taking a Lead From New Mexico

Frontiers in Pharmacology June 27, 2022 Snehal Bhatt, Maya Armstrong, Tassy Parker et al. 4 citations

Post-traumatic stress disorder (PTSD), a common condition with potentially devastating individual, family, and societal consequences, is highly associated with substance use disorders (SUDs). The association between PTSD and SUD is complex and may involve adverse childhood experiences (ACEs), historical and multi-generational traumas, and social determinants of health as well as cultural and...

DOI: 10.3389/fphar.2022.905753 (opens in new tab) Psychosocial Indigenous Psychological intervention Population +4

Characteristics of Sleep Paralysis and Its Association with Anxiety Symptoms, Perceived Stress, PTSD, and Other Variables Related to Lifestyle in Selected High Stress Exposed Professions.

International Journal of Environmental Research and Public Health June 25, 2022 Paulina Wróbel-knybel, Michał Flis, Joanna Róg et al.

Sleep paralysis (SP) is a hypnagogic or hypnopompic state associated with the inability to move while conscious. Recurrent isolated sleep paralysis (RISP) is a type of REM parasomnia. Individuals experiencing anxiety disorders, PTSD, exposure to chronic stress, or shift work are at risk of developing this sleep disorder. This study aimed to assess: (1) the prevalence, frequency, and...

Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression.

Frontiers in Behavioral Neuroscience June 21, 2022 Caitlyn J Bartsch, Jacob C. Nordman

Treatment options for chronically aggressive individuals remain limited despite recent medical advances. Traditional pharmacological agents used to treat aggression, such as atypical antipsychotics, have limited efficacy and are often replete with dangerous side effects. The non-competitive NMDAR antagonists ketamine and memantine are promising alternatives, but their effects appear to be...

The Effectiveness of Mindfulness-Based Cognitive Therapy in the Management of Tinnitus.

The international tinnitus journal June 21, 2022 Chanchai Jariengprasert, Kasinee Watanapornmongkol, Sivaporn Kiatthanabumrung et al.

Mindfulness-based cognitive therapy (MBCT) has been suggested as an effective modality in reducing the effects of tinnitus and improving quality of life. This article aimed to compare the effectiveness of MBCT with that of standard treatment in the management of tinnitus in Thai patients. All participants were voluntarily divided into experimental MBCT and control groups depending on their...

DOI: 10.5935/0946-5448.20220001 (opens in new tab) Full text (opens in new tab) Cognitive behavioral therapy Mindfulness therapy Tinnitus

The Neuroimaging Documentation of Psychedelic Drugs’ Effect on the Brain: dmt, lsd, Psilocybin, and Ibogaine as Examples: A Mini Review

Brain and Neurological Disorders June 21, 2022 Abdul Wahab Alahmari

Many psychedelics drugs are praised on social media platforms like YouTube by non-experts or bias documentaries claiming that these drugs have therapeutic effects on addicted patients or clarity of the mind. The aim of this paper is to collect a neuroimaging documentation of these psychedelics’ drugs and their effect on the brain. That can be documented on MRI, CT, or any other imaging modalities.

What if consciousness is not an emergent property of the brain? Observational and empirical challenges to materialistic models

PsyArXiv June 18, 2022 Helané Wahbeh, Dean Radin, Cedric Cannard et al. preprint

The nature of consciousness is considered one of the most perplexing and persistent mysteries in science. We all know the subjective experience of consciousness, but where does it arise? What is its purpose? What are its full capacities? The assumption within today’s neuroscience is that all aspects of consciousness arise solely from interactions among neurons in the brain. However, the origin...

Applying Lessons From Cannabis to the Psychedelic Highway

JAMA Health Forum June 17, 2022 Kevin F. Boehnke, Alan K. Davis, Jenna McAfee 20 citations

In 2020, Oregon became the first state in the US to decriminalize use of many illicit substances, including mushrooms containing psilocybin, and allow adults aged 21 years and older to take psilocybin under supervision in state-licensed service centers.Numerous states and municipalities have since proposed similar policies, 1 a process catalyzed by excitement about positive clinical trials of...

From Underground to Mainstream: Establishing a Medical Lexicon for Psychedelic Therapy

Frontiers in Psychiatry June 17, 2022 Andrew Beswerchij, Dominic Sisti 9 citations

We argue that non-stigmatizing and precise terminology grounded in the medical model will advance both the science and public acceptance of psychedelics. Researchers and clinicians should take care to distinguish between medical, recreational, and spiritual uses to set clear boundaries and expectations for patients. Ethically fraught or stigmatizing terms should be replaced with terminology...

DOI: 10.3389/fpsyt.2022.870507 (opens in new tab) Terminology Lexicon Mainstream Informed consent +5